Pancreatic Cyst
53
19
22
14
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.8%
2 terminated out of 53 trials
87.5%
+1.0% vs benchmark
4%
2 trials in Phase 3/4
0%
0 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (53)
In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers
The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts
Pancreas Registry and High Risk Registry
Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging in Patients With Pancreatic Cysts Undergoing Surgical Resection
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms
UCSF PANC Cyst Registry
PROMs After Pancreatectomy
Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry
Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features
Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection
Artificial Intelligence in Endoscopic Ultrasound
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic Adenocarcinoma
The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)
EUS-guided Ablation of Pancreatic Cyst Neoplasms